#ensitrelvir

Explore our comprehensive coverage of ensitrelvir, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

1Articles

1Authors

30Total Views

FDA Approves Xocova: First Oral Pill for Post-Exposure COVID-19 Prevention Marks Major 2026 Milestone

Featured

By Ayesha Noor HassanJun 19, 2026

FDA Approves Xocova: First Oral Pill for Post-Exposure COVID-19 Prevention Marks Major 2026 Milestone

The FDA has approved Xocova (ensitrelvir) as the first oral antiviral for post-exposure COVID-19 prevention, offering a highly accessible, pill-based ...

Read Full Story →

#ensitrelvir

FDA Approves Xocova: First Oral Pill for Post-Exposure COVID-19 Prevention Marks Major 2026 Milestone

Recent Articles